Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Yucha

Orthopaedic Surgery Chester, PA Medical Doctor

NPI 1164624797 CMS profile 52426

1 Medical Center Blvd, Pob Ii, Suite 324, Chester, PA 19013

Open in the dashboard

General payments

$131,345

273 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Yucha of Chester, PA is reported in the CMS Open Payments database as having received $131,345 across 273 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,738 25
2024 General $2,240 8
2023 General $4,038 17
2022 General $19,838 40
2021 General $31,528 65
2020 General $296 14
2019 General $61,667 104

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Yucha
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to David Yucha were reported at $11,738. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year David Yucha Orthopaedic Surgery median Middle half National median
2019 $61,667 $644 $140–$2,844 $163
2020 $296 $312 $75–$1,860 $114
2021 $31,528 $520 $117–$2,495 $132
2022 $19,838 $598 $128–$2,731 $149
2023 $4,038 $461 $128–$2,264 $160
2024 $2,240 $497 $134–$2,475 $164
2025 $11,738 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $104,944 163 payments
  2. Flexion Therapeutics, Inc. $20,516 58 payments
  3. AcelRx Pharmaceuticals, Inc. $2,036 3 payments
  4. Medical Device Business Services, Inc. $1,755 1 payment
  5. Stryker Corporation $913 8 payments
  6. Medacta USA, Inc. $478 5 payments
  7. DePuy Synthes Sales Inc. $169 9 payments
  8. Eclipse Technology Solutions Inc. $140 3 payments
  9. Avanos Medical $80 4 payments
  10. Heraeus Medical, LLC. $57 5 payments
  11. Other $257 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $93,880 35 payments
  2. Honoraria $21,775 9 payments
  3. Travel and Lodging $9,098 50 payments
  4. Food and Beverage $6,584 178 payments
  5. Education $8 1 payment
Products named General payments · program years 2019–2025
  1. Toggleloc $48,778 18 payments
  2. Juggerknot $46,316 49 payments
  3. Switchcut Instruments $22,191 6 payments
  4. Zilretta $20,516 58 payments
  5. Quatro Suture Passer $17,447 6 payments
  6. Washerloc $9,141 5 payments
  7. Biowick $6,853 3 payments
  8. SpeedSnare $6,750 2 payments
  9. Tunneloc Tibial Fixation $4,000 1 payment
  10. DSUVIA $2,036 3 payments
  11. Other $8,028 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

582

Median for Orthopedic Surgery: 203

Drug cost

$3,872

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 138 $2,338
Meloxicam Generic 325 $1,158
Gabapentin Generic 70 $291
Tramadol Hcl Generic 32 $55
Amoxicillin Generic 17 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$132,725

Of which drugs: $46,704

Medicare patients

338

Average age 74

Services billed

1,987

211 women, 127 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 28%
Ischemic heart disease 25%
Depression 21%
Atrial fibrillation 18%
Chronic kidney disease 17%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 56 93 $37,213
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 125 484 $2,502

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

273 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record